Patient Pathfinder: Clinical Trials
Clinical Trials for Colon Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 174 active Colon Cancer trials
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
Study Type: Interventional Early Phase 1
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
Study Type: Interventional Phase 2
Young-Onset Colorectal Cancer
Study Type: Observational
CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab
Study Type: Interventional Phase 1
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Study Type: Interventional Phase 1
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Study Type: Observational
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Study Type: Interventional Phase 2
There are 174 active Colon Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now